title: Intestinal Microbiota and Metabolic Diseases: Pharmacological Implications.
abstract: An increasing number of studies show that alterations in intestinal microbiota are linked with metabolic diseases. Here, we propose that intestinal microbiota regulation by polyphenols may be an important mechanism underlying their therapeutic benefits for metabolic diseases. This helps elucidate the intriguing pharmacology of polyphenols and optimize the treatment of metabolic diseases.
authors.affiliation: Shandong Provincial Research Center for Bioinformatic Engineering and Technique, School of Life Sciences, Shandong University of Technology, Zibo 255049, PR China. Electronic address: shen@sdut.edu.cn.
authors.forename: Liang
authors.initials: L
authors.lastname: Shen
authors.affiliation: Shandong Provincial Research Center for Bioinformatic Engineering and Technique, School of Life Sciences, Shandong University of Technology, Zibo 255049, PR China. Electronic address: jhf@sdut.edu.cn.
authors.forename: Hong-Fang
authors.initials: HF
authors.lastname: Ji
mesh_terms: D006801:Humans; D007422:Intestines / Q000382:microbiology*; D008659:Metabolic Diseases / Q000188:drug therapy* / Q000382:microbiology*; D064307:Microbiota; D059808:Polyphenols / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D059808:Polyphenols
keywords: intestinal microbiota; metabolic diseases; pharmacology; polyphenols